The Business Research Company’s report on the Pharmaceutical Fill and Finish Outsourcing Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How have key drivers contributed to the rapid growth of the pharmaceutical fill and finish outsourcing market?
The rising demand for biologic drugs is expected to propel the growth of the pharmaceutical fill and finish outsourcing market going forward. Biologic drugs, also known as biologics or biosimilars, are a class of pharmaceutical products derived from living organisms or containing components of living organisms. Drug manufacturers can use the skills and infrastructure of contract manufacturing organizations (CMOs) by outsourcing the fill and finish phase of production, allowing pharmaceutical companies to focus on the development, research, and scale-up of their biologic drugs while relying on CMOs for efficient and cost-effective fill and finish operations. For instance, in September 2023, according to the Association for Accessible Medicines (AAM), a US-based trade association for generic prescription drugs and pharmaceutical chemicals manufacturers, in 2022, annual savings from biosimilars drugs surpassed $408 billion, marking a $35 billion increase compared to 2021. This reflects a consistent yearly growth rate of 7–10 percent in savings over recent years. Therefore, the rising demand for biologic drugs will the pharmaceutical fill and finish the outsourcing market.
Access Your Free Sample of the Global Pharmaceutical Fill and Finish Outsourcing Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12069&type=smp
How has the pharmaceutical fill and finish outsourcing market size evolved, and what are the latest forecasts for its expansion?
The pharmaceutical fill and finish outsourcing market size has grown strongly in recent years. It will grow from $3.53 billion in 2024 to $3.78 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to the emergence of contract development and manufacturing organizations (CDMOs, demand for specialized services, shift to outsourced models, market expansion strategies, and stringent regulatory requirements
The pharmaceutical fill and finish outsourcing market size is expected to see strong growth in the next few years. It will grow to $5.28 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to demand for specialized services, global market expansion, focus on core competencies, rapid market entry for new drugs, flexibility in manufacturing capacity, anticipated need for flexible manufacturing capacity to accommodate fluctuation. Major trends in the forecast period include increased biologics outsourcing, sustainability initiatives, geographic expansion of outsourcing hubs, technological integration for efficiency, rise in contract development and manufacturing organizations (CDMOs).
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12069&type=smp
Which major companies dominate the pharmaceutical fill and finish outsourcing market?
Major companies operating in the pharmaceutical fill and finish outsourcing market include Groninger and Co. GmbH, Merck and Co.Inc., Abbott Laboratories, Wockhardt Limited., Boehringer Ingelheim International GmbH, Becton Dickinson and Company, AbbVie Inc., Teva Pharmaceuticals Industries Ltd., Recipharm AB., Lonza Group AG, Catalent Inc., Dr. Reddys Laboratories Ltd., West Pharmaceutical Services Inc., Sun Pharmaceutical Industries Ltd., Patheon N.V., Piramal Enterprises Ltd., Gerresheimer AG, CordenPharma International, Fujifilm Diosynth Biotechnologies, Optima Packaging Group GmbH, Jubilant HollisterStier LLC., Ajinomoto Bio-Pharma Services, Cytovance Biologics Inc., Grand River Aseptic Manufacturing, Baxter Pharmaceutical Solutions LLC., Halo Pharma Inc., MabPlex Inc., August Bioservices
What trends will shape the future of the pharmaceutical continuous manufacturing market?
Product innovations are a key trend gaining popularity in the pharmaceutical fill and finish outsourcing market. Companies operating in the pharmaceutical fill and finish outsourcing market are developing new innovative products to sustain their position in the market. For instance, in January 2024, Stevanato Group, an Italy-based provider of drug containment and delivery solutions to the pharmaceutical and life sciences industries launched the EZ-fill Kit and laboratory fill and finish service. The EZ-fillKit is designed to streamline the filling process for small batches of injectable drugs, making it particularly useful during clinical trials and early commercial stages and helps pharmaceutical companies by streamlining small batch production, reducing costs, and speeding up time-to-market. Additionally, their new non-GMP laboratory fill and finish service, allows for early assessment of how the fill-and-finish process impacts product performance. These innovations are geared towards improving efficiency and ensuring high standards in drug development and production.
Which region dominates the pharmaceutical fill and finish outsourcing market, and what factors contribute to its leadership?
North America was the largest region in the pharmaceutical fill and finish outsourcing market in 2024. The regions covered in the pharmaceutical fill and finish outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
How is the pharmaceutical fill and finish outsourcing market segmented, and which segment holds the largest share?
The pharmaceutical fill and finish outsourcing market covered in this report is segmented –
1) By State Of Finished Products: Liquid, Solids, Semi Solids
2) By Content: Organic Substances Isolated From Animal Origin, Organic Substances Isolated From Microorganisms, Inorganic Substances
3) By End-Users: Biopharmaceutical Companies, Pharmaceutical Companies
Subsegments:
1) By Liquid: Injectables Solutions Suspensions
2) By Solids: Tablets Capsules Powders
3) By Semi-Solids: Ointments Creams Gels
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12069
How is the pharmaceutical fill and finish outsourcing market defined?
Pharmaceutical fill and finish outsourcing is the practice of contracting with specialized pharmaceutical manufacturing companies to offer pharmaceutical filling and sealing operations into end-use containers with appropriate sterility and accuracy. These services are utilized by pharmaceutical and biopharmaceutical companies for specialized people with experience, costly automated equipment acquisitions, stringent regulatory agency inspection, increased efficiency, and flexibility in terms of production capacity.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
